224 results on '"Xie, Zuoquan"'
Search Results
2. SYK-mediated epithelial cell state is associated with response to c-Met inhibitors in c-Met-overexpressing lung cancer
3. Integrated multi-omics analysis reveals gut microbiota dysbiosis and systemic disturbance in major depressive disorder
4. Ecto-nucleotide pyrophosphatase/phosphodiesterase 1 inhibitors: Research progress and prospects
5. Structural insights into a shared mechanism of human STING activation by a potent agonist and an autoimmune disease-associated mutation
6. Structure−Activity relationship study of benzothiophene oxobutanoic acid analogues leading to novel stimulator of interferon gene (STING) agonists
7. Discovery of novel Thieno[2,3-d]imidazole derivatives as agonists of human STING for antitumor immunotherapy using systemic administration
8. Anti-inflammatory germacrane-type sesquiterpene lactones from Vernonia sylvatica.
9. Discovery of novel ceramide analogs with favorable pharmacokinetic properties and combination with AKT inhibitor against colon cancer
10. Genomic characterization of sarcomatoid transformation in clear cell renal cell carcinoma
11. A novel STING agonist with systemic and durable anti‐tumour activity
12. Sodium oligomannate therapeutically remodels gut microbiota and suppresses gut bacterial amino acids-shaped neuroinflammation to inhibit Alzheimer’s disease progression
13. Engineering a HER2-CAR-NK Cell Secreting Soluble Programmed Cell Death Protein with Superior Antitumor Efficacy
14. MP04-20 CHARACTERIZATION OF MITOCHONDRIAL DYSFUNCTION IN MODELS OF RENAL ONCOCYTOMA
15. Supplementary figure S7 from JX06 Selectively Inhibits Pyruvate Dehydrogenase Kinase PDK1 by a Covalent Cysteine Modification
16. Supplementary Figure S1: Analysis of the total of CNV events by region for the five mixed ccA/B tumors. from Genomic Heterogeneity and the Small Renal Mass
17. Supplementary Table S2 from JX06 Selectively Inhibits Pyruvate Dehydrogenase Kinase PDK1 by a Covalent Cysteine Modification
18. Supplementary information from JX06 Selectively Inhibits Pyruvate Dehydrogenase Kinase PDK1 by a Covalent Cysteine Modification
19. Supplementary Figure S3: Heat Map of Cohort from Genomic Heterogeneity and the Small Renal Mass
20. Data from Genomic Heterogeneity and the Small Renal Mass
21. Data from JX06 Selectively Inhibits Pyruvate Dehydrogenase Kinase PDK1 by a Covalent Cysteine Modification
22. Supplementary Movie S1 from JX06 Selectively Inhibits Pyruvate Dehydrogenase Kinase PDK1 by a Covalent Cysteine Modification
23. Supplementary Figure S2: PCA Map of Small (circle) and Large (triangle) tumors from Genomic Heterogeneity and the Small Renal Mass
24. Supplementary Figure S4: Minimal Correlation of Gene Expression and subclonal CNV events. from Genomic Heterogeneity and the Small Renal Mass
25. Fine-tuning bacterial cyclic di-AMP production for durable antitumor effects through the activation of the STING pathway
26. Acid‐Ionizable Iron Nanoadjuvant Augments STING Activation for Personalized Vaccination Immunotherapy of Cancer
27. Photochemically controlled activation of STING by CAIX-targeting photocaged agonists to suppress tumor cell growth
28. Dynamic Graph Attention Recurrent Network for Traffic Prediction
29. MRA-DGCN: Multi-Range Attention-Based Dynamic Graph Convolutional Network for Traffic Prediction
30. Preclinical evaluation of 3D185, a novel potent inhibitor of FGFR1/2/3 and CSF-1R, in FGFR-dependent and macrophage-dominant cancer models
31. Integrated Module of Multidimensional Omics for Peripheral Biomarkers (iMORE) in patients with major depressive disorder: rationale and design of a prospective multicentre cohort study
32. PCKT: Problem Composition in Knowledge Tracking
33. Discovery of Novel Imidazo[4,5-c]quinoline Derivatives to Treat Inflammatory Bowel Disease (IBD) by Inhibiting Multiple Proinflammatory Signaling Pathways and Restoring Intestinal Homeostasis
34. Geng et al. reply
35. Targeting sphingosine-1-phosphate signaling for cancer therapy
36. Development of a novel lactate dehydrogenase A inhibitor with potent antitumor activity and immune activation
37. Chronic Kidney Disease and Cognitive Impairment: The Kidney-Brain Axis
38. Withaphysalins from Medicinal and Edible Physalis minima and Their Anti-inflammatory Activities
39. Novel Sphingosine Kinase 1 Inhibitor Suppresses Growth of Solid Tumor and Inhibits the Lung Metastasis of Triple-Negative Breast Cancer
40. HER2/PD1 bispecific antibody in IgG4 subclass with superior anti‐tumour activities
41. Novel Plasma miRNAs as Biomarkers and Therapeutic Targets of Alzheimer’s Disease at the Prodromal Stage
42. GENOMIC CHARACTERIZATION OF SARCOMATOID TRANSFORMATION IN CLEAR CELL RENAL CELL CARCINOMA: MP71-12
43. Analysis of transcriptome and metabolome profiles alterations in fatty liver induced by high-fat diet in rat
44. The role of histone deacetylase 7 (HDAC7) in cancer cell proliferation: regulation on c-Myc
45. A novel long non-coding RNA-ARA: Adriamycin Resistance Associated
46. Structure–Activity Relationship Study of Amidobenzimidazole Analogues Leading to Potent and Systemically Administrable Stimulator of Interferon Gene (STING) Agonists
47. Grb14 as an Independent Good Prognosis Factor for Breast Cancer Patients Treated with Neoadjuvant Chemotherapy
48. Oligomannurarate sulfate sensitizes cancer cells to doxorubicin by inhibiting atypical activation of NF-κB via targeting of Mre11
49. Plasma miRNAs as Biomarkers for Amnestic Mild Cognitive Impairment and Modulation on BACE1
50. Abstract A83: In vitro and In vivo antitumor activity of immune suppressant FTY720
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.